Clinicopathological features and risk stratification by the sokal score of patients with chronic myeloid leukemia at a tertiary care hospital in North-East India: A prospective study

Background: Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by excessive growth of myeloid cells and their progenitors. The incidence of CML is approximately 1–2/100,000 population per year. Aims and Objectives: The aims and objectives of the study are to determine the clini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian Journal of Medical Sciences 2024-06, Vol.15 (6), p.101-106
Hauptverfasser: Anjanjyoti Rajkonwar, Upam Kumar Sharma, Sima Sonowal, Arpita Nath, Hiranya Saikia, Gautam Hazarika
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 6
container_start_page 101
container_title Asian Journal of Medical Sciences
container_volume 15
creator Anjanjyoti Rajkonwar
Upam Kumar Sharma
Sima Sonowal
Arpita Nath
Hiranya Saikia
Gautam Hazarika
description Background: Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by excessive growth of myeloid cells and their progenitors. The incidence of CML is approximately 1–2/100,000 population per year. Aims and Objectives: The aims and objectives of the study are to determine the clinicopathological features of patients with CML and their risk stratification by the Sokal score at a tertiary care hospital in North-East India. Materials and Methods: This was a single-center prospective study conducted for 5 years (2018–2022). A total of 109 cases diagnosed with CML by qualitative analysis of BCR-ABL1 transcript reverse transcription-polymerase chain reaction were included in the study. The Sokal score was calculated using previously published formulae to classify the patients into different risk groups. The outcome (dead or alive) of CML patients was compared with their individual risk groups using Fisher’s exact test. Results: Out of 109 CML patients, 73 were males and 36 were females. At the end of the study, 85 patients were alive whereas 24 died. The mean age at presentation was 42.08±15.06 years. The pediatric age group comprises 1.84% of total cases. The percentages of death were higher (79.17%) in patients aged 18–59 years, followed by 20.83% in ≥60 years age group, whereas no death was recorded in the pediatric age group (
doi_str_mv 10.71152/ajms.v15i6.3622
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_71152_ajms_v15i6_3622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_71152_ajms_v15i6_3622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c832-81de9f4634416fcfb9d367008da0de941a0830d4f9f32a7ccdcc5ea4d5ce4f833</originalsourceid><addsrcrecordid>eNotkMtOAzEMRUcIJCronqV_YEoymSe7qipQqYJN9yM3D8btdFIladH8GN9HWvDGlnx9fHWT5ImzWcV5kT3j7uBnZ15QORNllt0kk4w1PGVFVd7GOS-rtOGM3SdT73csVsFZVotJ8rPoaSBpjxg629svktiD0RhOTnvAQYEjvwcfHAYycRvIDrAdIXQavN1HtZfWabAGIoP0EDx8U-hAds5GMhxG3VtS0OvTXh8IAQMgBO0CoRtBYjzurD9SiCwa4MO60KVL9AFWgyJ8gTkcXRRoGegcn4aTGh-TO4O919P__pBsXpebxXu6_nxbLebrVNYiS2uudGPyUuQ5L40020aJsmKsVsjiJufIasFUbhojMqykVFIWGnNVSJ2bWoiHhP1hZTTgnTbt0dEh2m45a6_Jt5fk22vy7SV58Qtly33z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinicopathological features and risk stratification by the sokal score of patients with chronic myeloid leukemia at a tertiary care hospital in North-East India: A prospective study</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Anjanjyoti Rajkonwar ; Upam Kumar Sharma ; Sima Sonowal ; Arpita Nath ; Hiranya Saikia ; Gautam Hazarika</creator><creatorcontrib>Anjanjyoti Rajkonwar ; Upam Kumar Sharma ; Sima Sonowal ; Arpita Nath ; Hiranya Saikia ; Gautam Hazarika</creatorcontrib><description>Background: Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by excessive growth of myeloid cells and their progenitors. The incidence of CML is approximately 1–2/100,000 population per year. Aims and Objectives: The aims and objectives of the study are to determine the clinicopathological features of patients with CML and their risk stratification by the Sokal score at a tertiary care hospital in North-East India. Materials and Methods: This was a single-center prospective study conducted for 5 years (2018–2022). A total of 109 cases diagnosed with CML by qualitative analysis of BCR-ABL1 transcript reverse transcription-polymerase chain reaction were included in the study. The Sokal score was calculated using previously published formulae to classify the patients into different risk groups. The outcome (dead or alive) of CML patients was compared with their individual risk groups using Fisher’s exact test. Results: Out of 109 CML patients, 73 were males and 36 were females. At the end of the study, 85 patients were alive whereas 24 died. The mean age at presentation was 42.08±15.06 years. The pediatric age group comprises 1.84% of total cases. The percentages of death were higher (79.17%) in patients aged 18–59 years, followed by 20.83% in ≥60 years age group, whereas no death was recorded in the pediatric age group (&lt;18 years). The abdominal hard lump was the most common clinical presentation, followed by abdominal fullness, weakness, and pain abdomen. The Sokal score assigns the majority (66.06%) of patients to the intermediate risk (IR) category, followed by 25.69% and 8.26% in the high-risk (HR) and low-risk (LR) categories, respectively. It was observed that the majority (28.57%) of patients died in the HR group, followed by 20.83% in the IR group and 11.11% in the LR group. Conclusion: The mean age of CML patients is lower than that observed in many Western countries. The Sokal score assigns the majority of patients to IR category and the maximum death were seen in the HR group.</description><identifier>ISSN: 2467-9100</identifier><identifier>EISSN: 2091-0576</identifier><identifier>DOI: 10.71152/ajms.v15i6.3622</identifier><language>eng</language><ispartof>Asian Journal of Medical Sciences, 2024-06, Vol.15 (6), p.101-106</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Anjanjyoti Rajkonwar</creatorcontrib><creatorcontrib>Upam Kumar Sharma</creatorcontrib><creatorcontrib>Sima Sonowal</creatorcontrib><creatorcontrib>Arpita Nath</creatorcontrib><creatorcontrib>Hiranya Saikia</creatorcontrib><creatorcontrib>Gautam Hazarika</creatorcontrib><title>Clinicopathological features and risk stratification by the sokal score of patients with chronic myeloid leukemia at a tertiary care hospital in North-East India: A prospective study</title><title>Asian Journal of Medical Sciences</title><description>Background: Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by excessive growth of myeloid cells and their progenitors. The incidence of CML is approximately 1–2/100,000 population per year. Aims and Objectives: The aims and objectives of the study are to determine the clinicopathological features of patients with CML and their risk stratification by the Sokal score at a tertiary care hospital in North-East India. Materials and Methods: This was a single-center prospective study conducted for 5 years (2018–2022). A total of 109 cases diagnosed with CML by qualitative analysis of BCR-ABL1 transcript reverse transcription-polymerase chain reaction were included in the study. The Sokal score was calculated using previously published formulae to classify the patients into different risk groups. The outcome (dead or alive) of CML patients was compared with their individual risk groups using Fisher’s exact test. Results: Out of 109 CML patients, 73 were males and 36 were females. At the end of the study, 85 patients were alive whereas 24 died. The mean age at presentation was 42.08±15.06 years. The pediatric age group comprises 1.84% of total cases. The percentages of death were higher (79.17%) in patients aged 18–59 years, followed by 20.83% in ≥60 years age group, whereas no death was recorded in the pediatric age group (&lt;18 years). The abdominal hard lump was the most common clinical presentation, followed by abdominal fullness, weakness, and pain abdomen. The Sokal score assigns the majority (66.06%) of patients to the intermediate risk (IR) category, followed by 25.69% and 8.26% in the high-risk (HR) and low-risk (LR) categories, respectively. It was observed that the majority (28.57%) of patients died in the HR group, followed by 20.83% in the IR group and 11.11% in the LR group. Conclusion: The mean age of CML patients is lower than that observed in many Western countries. The Sokal score assigns the majority of patients to IR category and the maximum death were seen in the HR group.</description><issn>2467-9100</issn><issn>2091-0576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNotkMtOAzEMRUcIJCronqV_YEoymSe7qipQqYJN9yM3D8btdFIladH8GN9HWvDGlnx9fHWT5ImzWcV5kT3j7uBnZ15QORNllt0kk4w1PGVFVd7GOS-rtOGM3SdT73csVsFZVotJ8rPoaSBpjxg629svktiD0RhOTnvAQYEjvwcfHAYycRvIDrAdIXQavN1HtZfWabAGIoP0EDx8U-hAds5GMhxG3VtS0OvTXh8IAQMgBO0CoRtBYjzurD9SiCwa4MO60KVL9AFWgyJ8gTkcXRRoGegcn4aTGh-TO4O919P__pBsXpebxXu6_nxbLebrVNYiS2uudGPyUuQ5L40020aJsmKsVsjiJufIasFUbhojMqykVFIWGnNVSJ2bWoiHhP1hZTTgnTbt0dEh2m45a6_Jt5fk22vy7SV58Qtly33z</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Anjanjyoti Rajkonwar</creator><creator>Upam Kumar Sharma</creator><creator>Sima Sonowal</creator><creator>Arpita Nath</creator><creator>Hiranya Saikia</creator><creator>Gautam Hazarika</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240601</creationdate><title>Clinicopathological features and risk stratification by the sokal score of patients with chronic myeloid leukemia at a tertiary care hospital in North-East India: A prospective study</title><author>Anjanjyoti Rajkonwar ; Upam Kumar Sharma ; Sima Sonowal ; Arpita Nath ; Hiranya Saikia ; Gautam Hazarika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c832-81de9f4634416fcfb9d367008da0de941a0830d4f9f32a7ccdcc5ea4d5ce4f833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anjanjyoti Rajkonwar</creatorcontrib><creatorcontrib>Upam Kumar Sharma</creatorcontrib><creatorcontrib>Sima Sonowal</creatorcontrib><creatorcontrib>Arpita Nath</creatorcontrib><creatorcontrib>Hiranya Saikia</creatorcontrib><creatorcontrib>Gautam Hazarika</creatorcontrib><collection>CrossRef</collection><jtitle>Asian Journal of Medical Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anjanjyoti Rajkonwar</au><au>Upam Kumar Sharma</au><au>Sima Sonowal</au><au>Arpita Nath</au><au>Hiranya Saikia</au><au>Gautam Hazarika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathological features and risk stratification by the sokal score of patients with chronic myeloid leukemia at a tertiary care hospital in North-East India: A prospective study</atitle><jtitle>Asian Journal of Medical Sciences</jtitle><date>2024-06-01</date><risdate>2024</risdate><volume>15</volume><issue>6</issue><spage>101</spage><epage>106</epage><pages>101-106</pages><issn>2467-9100</issn><eissn>2091-0576</eissn><abstract>Background: Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by excessive growth of myeloid cells and their progenitors. The incidence of CML is approximately 1–2/100,000 population per year. Aims and Objectives: The aims and objectives of the study are to determine the clinicopathological features of patients with CML and their risk stratification by the Sokal score at a tertiary care hospital in North-East India. Materials and Methods: This was a single-center prospective study conducted for 5 years (2018–2022). A total of 109 cases diagnosed with CML by qualitative analysis of BCR-ABL1 transcript reverse transcription-polymerase chain reaction were included in the study. The Sokal score was calculated using previously published formulae to classify the patients into different risk groups. The outcome (dead or alive) of CML patients was compared with their individual risk groups using Fisher’s exact test. Results: Out of 109 CML patients, 73 were males and 36 were females. At the end of the study, 85 patients were alive whereas 24 died. The mean age at presentation was 42.08±15.06 years. The pediatric age group comprises 1.84% of total cases. The percentages of death were higher (79.17%) in patients aged 18–59 years, followed by 20.83% in ≥60 years age group, whereas no death was recorded in the pediatric age group (&lt;18 years). The abdominal hard lump was the most common clinical presentation, followed by abdominal fullness, weakness, and pain abdomen. The Sokal score assigns the majority (66.06%) of patients to the intermediate risk (IR) category, followed by 25.69% and 8.26% in the high-risk (HR) and low-risk (LR) categories, respectively. It was observed that the majority (28.57%) of patients died in the HR group, followed by 20.83% in the IR group and 11.11% in the LR group. Conclusion: The mean age of CML patients is lower than that observed in many Western countries. The Sokal score assigns the majority of patients to IR category and the maximum death were seen in the HR group.</abstract><doi>10.71152/ajms.v15i6.3622</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2467-9100
ispartof Asian Journal of Medical Sciences, 2024-06, Vol.15 (6), p.101-106
issn 2467-9100
2091-0576
language eng
recordid cdi_crossref_primary_10_71152_ajms_v15i6_3622
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
title Clinicopathological features and risk stratification by the sokal score of patients with chronic myeloid leukemia at a tertiary care hospital in North-East India: A prospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A07%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathological%20features%20and%20risk%20stratification%20by%20the%20sokal%20score%20of%20patients%20with%20chronic%20myeloid%20leukemia%20at%20a%20tertiary%20care%20hospital%20in%20North-East%20India:%20A%20prospective%20study&rft.jtitle=Asian%20Journal%20of%20Medical%20Sciences&rft.au=Anjanjyoti%20Rajkonwar&rft.date=2024-06-01&rft.volume=15&rft.issue=6&rft.spage=101&rft.epage=106&rft.pages=101-106&rft.issn=2467-9100&rft.eissn=2091-0576&rft_id=info:doi/10.71152/ajms.v15i6.3622&rft_dat=%3Ccrossref%3E10_71152_ajms_v15i6_3622%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true